We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Lymphocyte Activation Gene (LAG)-3 Is Associated With Mucosal Inflammation and Disease Activity in Ulcerative Colitis.
- Authors
Slevin, Stephanie M; Garner, Lucy C; Lahiff, Conor; Tan, Malcolm; Wang, Lai Mun; Ferry, Helen; Greenaway, Borgel; Lynch, Kate; Geremia, Alessandra; Hughes, Stephen; Leavens, Karen; Krull, David; Marks, Daniel J B; Nevin, Katherine; Page, Kevin; Srinivasan, Naren; Tarzi, Ruth; Klenerman, Paul; Travis, Simon; Arancibia-Cárcamo, Carolina V
- Abstract
Background and Aims Lymphocyte activation gene [LAG]-3 is an immune checkpoint and its expression identifies recently activated lymphocytes that may contribute to inflammation. We investigated the role of LAG-3 by analysing its expression and function in immune cells from blood and tissue of patients with ulcerative colitis [UC]. Methods The phenotypic properties of LAG-3+ T cells were determined by flow cytometry, qRT-PCR and single-cell RNA-sequencing. LAG-3+ cells were quantified and correlated with disease activity. The functional effects of LAG-3+ cells were tested using a depleting anti-LAG-3 monoclonal antibody [mAb] in a mixed lymphocyte reaction [MLR]. Results LAG-3+ cells in the blood were negligible. LAG-3+ lymphocytes were markedly increased in inflamed mucosal tissue and both frequencies of LAG-3+ T cells and transcript levels of LAG3 correlated with endoscopic severity. LAG-3 expression was predominantly on effector memory T cells, and single-cell RNA-sequencing revealed LAG3 expression in activated and cytokine-producing T cell subsets. Foxp3+CD25hi Tregs also expressed LAG-3, although most mucosal Tregs were LAG-3−. Mucosal LAG-3+ cells produced mainly interferon γ [IFNγ] and interleukin-17A. LAG-3+ cell numbers decreased in patients who responded to biologics, and remained elevated in non-responders. Treatment with a depleting anti-LAG-3 mAb led to a reduction in proliferation and IFNγ production in an MLR. Conclusions LAG-3+ cells are increased in the inflamed mucosa, predominantly on effector memory T cells with an activated phenotype and their cell numbers positively correlate with disease activity. Depleting LAG-3 eliminates activated proliferating T cells, and hence LAG-3 could be a therapeutic target in UC.
- Publication
Journal of Crohn's & Colitis, 2020, Vol 14, Issue 10, p1446
- ISSN
1873-9946
- Publication type
Article
- DOI
10.1093/ecco-jcc/jjaa054